Update on EGFR-mutated non-small cell lung cancer

Viečča ollesdeavstta

CompEx asthma a novel composite exacerbation endpoint /

Viečča ollesdeavstta
Series

Immunotherapy insights from advanced disease /

Viečča ollesdeavstta
Series

Ovarian cancer progression of tumors /

Viečča ollesdeavstta
Series

The evolving role of novel and next generation therapies in the management of multiple myeloma part 1 of 2, introduction and current therapies /

Viečča ollesdeavstta

The evolving role of novel and next generation therapies in the management of multiple myeloma part 2 of 2, relapse refractory multiple myeloma /

Viečča ollesdeavstta

Clinical trial designs for rare diseases part 1 of 2, trial designs /

Viečča ollesdeavstta

Clinical trial designs for rare diseases part 2 of 2, trial protocols /

Viečča ollesdeavstta

Management of sickle cell disease what to do when there is no evidence base /

Viečča ollesdeavstta

Research & development of new pharmaceuticals for treatment of endometriosis

Viečča ollesdeavstta

Lysosomal storage diseases

Viečča ollesdeavstta
Series

Latest developments & future directions in the management of chronic pain

Viečča ollesdeavstta
Series

Systemic lupus erythematosus novel aspects of pathogenesis and treatment, part 2 of 2 /

Viečča ollesdeavstta
Series

GPCRs and pain

Viečča ollesdeavstta
Series

Novel approaches to treating symptoms and slowing the progress of neurodegenerative diseases

Viečča ollesdeavstta
Series

Multiple myeloma an overview /

Viečča ollesdeavstta

Prolactin has a pathogenic role in systemic lupus erythematosus

Viečča ollesdeavstta
Series

Advances in the treatment of NASH

Viečča ollesdeavstta

Adapting proteostasis to ameliorate aggregation-associated amyloid diseases

Viečča ollesdeavstta
Series

Pharmacotherapy for obesity part 1, the need for pharmacotherapy in weight management /

Viečča ollesdeavstta